Analysis: Balaxi Pharmaceuticals Limited

NSE:BALAXI Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹139 cr

Research report

companyname: Balaxi Pharmaceuticals Limited ticker: BALAXI sector: Pharmaceuticals Balaxi Pharmaceuticals Limited is a branded IPR-driven pharmaceutical company that sells medicines in frontier and semi-regulated markets across Africa and Latin America. It does not operate like a typical Indian pharma exporter that manufactures and ships to distributors. Balaxi holds the product registrations in each country, stocks inventory in its own local warehouses, and sells through its own distribution n...

Read the full report →
RS rating: 60 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Balaxi Pharmaceuticals Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.